In poll season, Punjab debates legalising poppy seed and opium farming
Proponents feel the two crops will help farmers, save Punjab’s groundwater and wean its youth from synthetic drugs
Monsanto's troublesome trait
Bayer is battling seed companies and farmers in several countries over royalty on Monsanto's GM seeds
Germany to phase out glyphosate by 2023
The country took this step to protect insect populations that play a pivotal role in ecosystems and pollination of food crops
Beware of a deal with Trump
As the US president comes visiting to India there is worry about the demands he will make on intellectual property
Vaccines without needles: New shelf-stable film could revolutionise how medicines are distributed worldwide
A research group claims to have developed a method to stabilise live viruses and other biological medicines in a rapidly dissolving film that …
COVID-19: Centre brings package to boost bulk drugs
Indian pharma industry is critically dependent on imported raw material
COVID-19 exposes India’s dependence on China for active pharma ingredients
India imports around 90 per cent of APIs used to make antibiotics, says an expert
The world needs pharmaceuticals from China and India to beat COVID-19
Chinese manufacturers make around 40% of all APIs used worldwide; China, India are the source of 75-80% of APIs imported to US
COVID-19 exposed dependence of world, India on China for active pharma ingredients
APIs are crucial for drugs and countries have put their eggs in a single basket; India has been discussing the issue for sometime
COVID-19 also brings focus back on pollution due to pharmaceuticals
No time for quick-fix measures. India needs stricter laws
COVID-19 and the big pharma mess
The pandemic has exposed a serious fault line in the global pharmaceutical supply chain, created by an industry that flourished by putting profit …
Marxists vs Paternalists vs Liberals: Where healthcare stands in India
How health as a right, investment and consumption regularly crops up in capitalist discourses
Accident at Sainor unit in Vizag more proof of companies bypassing rules
Life-saving equipments were absent on-site though the company had approvals to show they were present
OxyContin maker Purdue Pharma may settle legal claims with a new ‘public trust’ that would still be dedicated to profit
Two similarly ambitious efforts to build alternatives to the profit-driven pharmaceutical model during and immediately after World War II suggest …
AMR driven by manufacturing our next big challenge
Antibiotics production is an important yet often forgotten driver of antimicrobial resistance; an alliance of pioneers has decided to pave the …
Antimicrobial resistance: The need to tackle access-excess problem
AMR, like every process, has its own drivers and determinants. The threat has evolved over time due to our acts of omission and commission
Microplastics all around: A silent epidemic
All types of sea creatures ingest microplastics; as they move up the food chain, the plastic ends up in the human gut
Dark underbelly of Big Pharma lobbying
Recent protests and campaigns in the US have focused on the proposal by India & South Africa at WTO to keep TRIPS in abeyance till the …
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
Big Pharma and intellectual property: Why is India afraid of compulsory licences?
While rich nations are discovering the virtues of compulsory drug licences, India has resolutely turned its back on this tool despite nudges from …
The end of meat and GMOs or the end of us: Part 1
The first in a three-part series series on effects of GMOs and the meat industry on our environment
When Big Pharma has all the answers
IFPMA, the biopharma trade body, has made its claim clear: COVID-19 vaccine management should be left to these handful of companies; and all …
National List of Essential Medicines: 34 drugs enlisted in update after 7 years
The latest National List of Essential Medicines features 384 medicines, drops 26 old ones
Rise of AMR could result in up to 10 million annual deaths by 2050: UN report
Some 24 million people could be pushed into extreme poverty due to rising AMR, the UNEP said
Why Americans pay more for prescription drugs than anywhere else globally
The root of the problem is a patent system that allows pharma companies to keep out competition and keep prices sky high
